Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Assess Safety and Efficacy of ELAD in Severe Acute Alcoholic Hepatitis Steroid Failures

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Vital Therapies, Inc.
Sponsor:
Information provided by (Responsible Party):
Vital Therapies, Inc.
ClinicalTrials.gov Identifier:
NCT01829347
First received: April 8, 2013
Last updated: October 29, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
No publications provided by Vital Therapies, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):